Atsushi Ishiguro

Methylation of the KEAP1 gene promoter region in human colorectal cancer

Naoyuki Hanada, Takenori Takahata, Qiliang Zhou et al. · BMC Cancer · 2012 · 188 citations · Full text

Life Sciences, Oncology, Epigenomics +7

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07

Yoshihiro Kakeji, Kazuhiro Yoshida, Yasuhiro Kodera et al. · Gastric Cancer · 2021 · 90 citations · Full text

Medicine, Oncology, Chemotherapy +6

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A Prospective Observational Study on Effect of Short-Term Periodic Steroid Premedication on Bone Metabolism in Gastrointestinal Cancer (ESPRESSO-01)

Michio Nakamura, Atsushi Ishiguro, Tetsuhito Muranaka et al. · The Oncologist · 2017 · 47 citations · Full text

Medicine, Oncology, Pharmacology +14